A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea
Status:
Completed
Trial end date:
2017-06-22
Target enrollment:
Participant gender:
Summary
The objectives of this study were to compare the safety and efficacy profiles of a generic
Azelaic Acid Foam, 15% to the reference listed Finacea® (azelaic acid) Foam, 15% and to
demonstrate therapeutic equivalence and safety of the two active foams in the treatment of
moderate facial rosacea, and to demonstrate superiority of the Reference and Test products
over the Vehicle.